What is Restor3d?
Headquartered in Durham, North Carolina, Restor3d operates at the intersection of additive manufacturing and clinical orthopedics. The company specializes in the development of 3D printed implants that offer enhanced integrative properties, effectively bridging the gap between traditional medical devices and patient-specific surgical needs. By integrating kinematic modeling with AI-based planning tools, Restor3d provides surgeons with a comprehensive ecosystem for complex reconstruction and repair procedures.
The firm's market position is defined by its ability to scale high-precision manufacturing while maintaining the rigorous standards required for medical-grade implants. As the healthcare industry shifts toward personalized medicine, Restor3d's focus on anatomical precision and material science positions it as a critical player in the future of musculoskeletal surgery.
How much funding has Restor3d raised?
Restor3d has raised a total of $324.1M across 7 funding rounds:
Unspecified
$4.3M
Other Financing Round
$23M
Series A
$55M
Private Equity
$15M
Multiple Rounds
$226.8M
Unspecified (2020): $4.3M, investors not publicly disclosed
Other Financing Round (2022): $23M, investors not publicly disclosed
Series A (2024): $55M supported by Summers Value Partners
Private Equity (2024): $15M featuring Trinity Capital
Other Financing Round (2025): $38M backed by Trinity Capital and Summers Value Partners
Private Equity (2025): $84.8M, investors not publicly disclosed
Private Equity (2025): $104M led by Partners Group
Key Investors in Restor3d
Summers Value Partners
A boutique investment manager specializing in concentrated value investing within the healthcare sector, focusing on small-cap companies undergoing structural transformation.
Trinity Capital
A specialized investment firm providing debt and equity solutions to growth-stage companies, often supporting firms through critical scaling phases.
Partners Group
A leading global private markets investment manager with a focus on institutional-grade assets and long-term value creation across diverse sectors.
What's next for Restor3d?
With the recent infusion of capital, Restor3d is well-positioned to scale its manufacturing capabilities and expand its clinical footprint. The strategic focus will likely center on deepening its AI-planning software suite and broadening its portfolio of biomedical materials to address a wider range of orthopedic indications. As the company moves into this next phase of growth, it will likely prioritize operational efficiency and the expansion of its distribution networks to meet the rising demand for patient-specific implants in global markets. The backing from institutional investors suggests a clear path toward long-term market leadership and potential future liquidity events.
See full Restor3d company page
